Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 5 of 30 for:    Saved Studies

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04686773
Recruitment Status : Active, not recruiting
First Posted : December 29, 2020
Last Update Posted : January 11, 2022
Russian Direct Investment Fund
The Gamaleya National Center of Epidemiology & Microbiology
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 1, 2021
Estimated Study Completion Date : March 7, 2022